Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinitis pigmentosa in which the cause of the disease is a mutation in the CRB1 gene.
Features include always present findings: Undetectable electroretinogram, Nystagmus, Reduced visual acuity, and Rod-cone dystrophy and others; and very common findings: Bone spicule pigmentation of the retina and Optic disc pallor. 10 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Nystagmus, Optic disc pallor, Attenuation of retinal blood vessels |
CRB1 encodes crumbs cell polarity complex component 1 (1,406 aa). Plays a role in photoreceptor morphogenesis in the retina. May maintain cell polarization and adhesion Highest expression in Brain Cerebellar Hemisphere (4.5 TPM) and Brain Cerebellum (4.5 TPM).
Retinitis pigmentosa 12 is associated with mutations in the CRB1 gene on chromosome 1.
CRB1 is classified as a druggable target (Druggable Genome category) with score 0.0.
Genetic testing for CRB1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for retinitis pigmentosa 12 has been reported in the published literature.
Phenotype severity distribution: 5 always present features, 2 very common features, 1 common feature.
No clinical trials have been registered for retinitis pigmentosa 12.
31 publications have been identified in PubMed for retinitis pigmentosa 12. Research spans Epidemiology / Natural History (29%), Case Report / Case Series (26%), and Basic Science / Preclinical (26%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 9 | 29% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 4:36 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Bones and joints |
1 |
Bone spicule pigmentation of the retina |
Patient case studies
8 |
26% |
Laboratory research | 8 | 26% |
Research summaries | 4 | 13% |
Testing and diagnosis research | 1 | 3% |
New treatment approaches | 1 | 3% |
Taha I (2026). [PMID: 41851861](https://pubmed.ncbi.nlm.nih.gov/41851861/). *BMC ophthalmology*. [Basic Science / Preclinical]
Rodriguez-Martinez AC (2026). [PMID: 41626423](https://pubmed.ncbi.nlm.nih.gov/41626423/). *Ophthalmology science*. [Epidemiology / Natural History]
Khan S (2026). [PMID: 42107829](https://pubmed.ncbi.nlm.nih.gov/42107829/). *Biochim Biophys Acta Proteins Proteom*. [Review / Meta-Analysis]
Hong Y (2026). [PMID: 41242591](https://pubmed.ncbi.nlm.nih.gov/41242591/). *American journal of ophthalmology*. [Case Report / Case Series]
Kahtan BE (2026). [PMID: 41490227](https://pubmed.ncbi.nlm.nih.gov/41490227/). *Retina (Philadelphia, Pa.)*. [Case Report / Case Series]
Xiao N (2026). [PMID: 41679029](https://pubmed.ncbi.nlm.nih.gov/41679029/). *Stem cell research*. [Basic Science / Preclinical]
Guala A (2025). [PMID: 40546236](https://pubmed.ncbi.nlm.nih.gov/40546236/). *American journal of medical genetics. Part A*. [Basic Science / Preclinical]
Castro J (2025). [PMID: 40416256](https://pubmed.ncbi.nlm.nih.gov/40416256/). *Cureus*. [Case Report / Case Series]
Tzou FY (2025). [PMID: 39965731](https://pubmed.ncbi.nlm.nih.gov/39965731/). *Biochimica et biophysica acta. Molecular basis of disease*. [Basic Science / Preclinical]
Mesquita R (2025). [PMID: 40725401](https://pubmed.ncbi.nlm.nih.gov/40725401/). *Genes*. [Epidemiology / Natural History]